Inovio Pharma (INO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -167,475 | -120,552 | -96,968 | -88,206 | -73,740 |
| Depreciation Amortization | 4,628 | 5,518 | 5,069 | 3,789 | 3,352 |
| Income taxes - deferred | N/A | 5 | N/A | -150 | -1 |
| Accounts receivable | -17,016 | 2,023 | 2,435 | 10,080 | -9,237 |
| Other Working Capital | -71,072 | -3,543 | 4,709 | 2,896 | -529 |
| Other Operating Activity | 72,955 | 18,698 | 11,204 | 8,382 | 17,600 |
| Operating Cash Flow | $-177,979 | $-97,850 | $-73,550 | $-63,209 | $-62,555 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -156,217 | -100,950 | -88,155 | -95,700 | 19,210 |
| PPE Investments | -1,521 | -988 | -2,085 | -10,294 | -2,739 |
| Purchase Of Investment | -1,400 | N/A | N/A | N/A | N/A |
| Sale Of Investment | 103,116 | 92,893 | 132,660 | 77,163 | N/A |
| Purchase Sale Intangibles | N/A | N/A | N/A | 1,000 | -200 |
| Other Investing Activity | -2,775 | 0 | 0 | 1,000 | -200 |
| Investing Cash Flow | $-58,796 | $-9,045 | $42,420 | $-27,831 | $16,272 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 172 | 97,444 | N/A | N/A | N/A |
| Debt Repayment | N/A | -3,315 | N/A | N/A | N/A |
| Common Stock Issued | 466,756 | 9,202 | 31,649 | 95,690 | 7,937 |
| Other Financing Activity | -1,648 | 2,067 | -612 | 0 | -150 |
| Financing Cash Flow | $465,280 | $105,398 | $31,037 | $95,690 | $7,787 |
| Exchange Rate Effect | 27 | N/A | N/A | N/A | N/A |
| Beginning Cash Position | 22,196 | 23,694 | 23,787 | 19,137 | 57,633 |
| End Cash Position | 250,728 | 22,196 | 23,694 | 23,787 | 19,137 |
| Net Cash Flow | $228,532 | $-1,498 | $-93 | $4,650 | $-38,496 |
| Free Cash Flow | |||||
| Operating Cash Flow | -177,979 | -97,850 | -73,550 | -63,209 | -62,555 |
| Capital Expenditure | -1,521 | -988 | -2,085 | -10,294 | -2,739 |
| Free Cash Flow | -179,500 | -98,838 | -75,635 | -73,503 | -65,294 |